Mus­tang Bio to sell Mass­a­chu­setts CAR-T man­u­fac­tur­ing fa­cil­i­ty

The CAR-T-cen­tered biotech Mus­tang Bio is sell­ing off its man­u­fac­tur­ing fa­cil­i­ty in Mass­a­chu­setts for $11 mil­lion.

Mus­tang Bio an­nounced on Thurs­day that it will be …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER